| XCL1 |
XCL1, LTN, SCYC1: Lymphotactin precursor |
HTR6 |
HTR6: 5-hydroxytryptamine receptor 6 |
0.632 |
Evidence |
|
| PTGIR |
PTGIR, PRIPR: Prostacyclin receptor |
CXCL12 |
Stromal cell-derived factor 1 delta |
0.632 |
Evidence |
|
| CXCL5 |
CXCL5, ENA78, SCYB5: Small-inducible cytokine B5 precursor |
CCR5 |
CCR5: CCR5 receptor (Fragment) |
0.632 |
Evidence |
|
| CXCL5 |
CXCL5, ENA78, SCYB5: Small-inducible cytokine B5 precursor |
GPR23 |
LPA4, GPR23, P2RY9: Lysophosphatidic acid receptor 4 |
0.632 |
Evidence |
|
| CXCL5 |
CXCL5, ENA78, SCYB5: Small-inducible cytokine B5 precursor |
CXCR4 |
CXCR4: C-X-C chemokine receptor type 4 |
0.632 |
Evidence |
|
| CXCL5 |
CXCL5, ENA78, SCYB5: Small-inducible cytokine B5 precursor |
P2RY4 |
P2RY4, NRU: P2Y purinoceptor 4 |
0.632 |
Evidence |
|
| LIFR |
LIFR: Leukemia inhibitory factor receptor precursor |
IL2 |
IL2: Interleukin 2 |
0.632 |
Evidence |
|
| FRK |
FRK, PTK5, RAK: Tyrosine-protein kinase FRK |
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
0.632 |
Evidence |
|
| FRK |
FRK, PTK5, RAK: Tyrosine-protein kinase FRK |
MERTK |
MERTK, MER: Proto-oncogene tyrosine-protein kinase MER precursor |
0.632 |
Evidence |
|
| FRK |
FRK, PTK5, RAK: Tyrosine-protein kinase FRK |
TEK |
TEK, TIE2: Angiopoietin-1 receptor precursor |
0.632 |
Evidence |
|
| TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
FLT3 |
FLT3, STK1: FL cytokine receptor precursor |
0.632 |
Evidence |
|
| TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
CBLC |
CBLC, CBL3, RNF57: Signal transduction protein CBL-C |
0.632 |
Evidence |
|
| TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
MERTK |
MERTK, MER: Proto-oncogene tyrosine-protein kinase MER precursor |
0.632 |
Evidence |
|
| CASP2 |
CASP2, ICH1, NEDD2: Caspase-2 precursor |
TNFRSF1A |
TNFRSF1A, TNFAR, TNFR1: Tumor necrosis factor receptor superfamily member 1A pre |
0.632 |
Evidence |
|
| RGS2 |
RGS2, G0S8: Regulator of G-protein signaling 2 |
GNA13 |
GNA13: Guanine nucleotide-binding protein alpha-13 subunit |
0.632 |
Evidence |
|
| TGFBR1 |
TGFBR1: TGF-beta receptor type-1 precursor |
GDF15 |
GDF15, MIC1, PDF, PLAB, PTGFB: Growth/differentiation factor 15 precursor |
0.632 |
Evidence |
|
| KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
INSL3 |
JAK3: Tyrosine-protein kinase JAK3 |
0.632 |
Evidence |
|
| CTNNB1 |
CTNNB1, CTNNB, OK/SW-cl.35, PRO2286: Catenin beta-1 |
DSC2 |
DSC2, DSC3: Desmocollin-2 precursor |
0.632 |
Evidence |
|
| TRHR |
TRHR: Thyrotropin-releasing hormone receptor |
CXCL9 |
CXCL9, CMK, MIG, SCYB9: Small-inducible cytokine B9 precursor |
0.632 |
Evidence |
|
| TRHR |
TRHR: Thyrotropin-releasing hormone receptor |
CCL8 |
CCL8, MCP2, SCYA10, SCYA8: Small-inducible cytokine A8 precursor |
0.632 |
Evidence |
|
| CDH5 |
CDH5: Cadherin-5 precursor |
CTNNB1 |
CTNNB1, CTNNB, OK/SW-cl.35, PRO2286: Catenin beta-1 |
0.632 |
Evidence |
|
| CIITA |
CIITA, MHC2TA: MHC class II transactivator |
TNFRSF1A |
TNFRSF1A, TNFAR, TNFR1: Tumor necrosis factor receptor superfamily member 1A pre |
0.632 |
Evidence |
|
| DSG3 |
DSG3: Desmoglein-3 precursor |
CTNNB1 |
CTNNB1, CTNNB, OK/SW-cl.35, PRO2286: Catenin beta-1 |
0.632 |
Evidence |
|
| SSTR3 |
SSTR3: Somatostatin receptor type 3 |
CCL13 |
CCL13, MCP4, NCC1, SCYA13: Small-inducible cytokine A13 precursor |
0.632 |
Evidence |
|
| SSTR3 |
SSTR3: Somatostatin receptor type 3 |
CXCL9 |
CXCL9, CMK, MIG, SCYB9: Small-inducible cytokine B9 precursor |
0.632 |
Evidence |
|